Zobrazeno 1 - 10
of 67
pro vyhledávání: '"M. M. Oken"'
Autor:
John P. Gockerman, Bruce A. Peterson, George P. Canellos, David D. Hurd, Barbara A. Parker, M. M. Oken, B D Cheson, G Petroni, David B. Duggan, J Johnson, J Prchal, Sonali M. Smith
Publikováno v:
Leukemia & Lymphoma. 50:1606-1617
Recombinant interferon alpha-2b (IFN-alpha2) has direct and indirect antiproliferative effects in lymphoma, and may augment cytotoxicity when combined with chemotherapy. CALGB 8691 is a randomized study of daily oral cyclophosphamide (CPA) at 100 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eeb1e8e024800c7605ca6f4cdae0526
https://doi.org/10.1080/10428190903093807
https://doi.org/10.1080/10428190903093807
Autor:
P A, Cassileth, E, Lynch, J D, Hines, M M, Oken, J J, Mazza, J M, Bennett, P B, McGlave, M, Edelstein, D P, Harrington, M J, O'Connell
Publikováno v:
Blood. 79:1924-1930
The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abfb5f8d2d44e187d4a6db94b60b7bd
https://doi.org/10.1182/blood.v79.8.1924.1924
https://doi.org/10.1182/blood.v79.8.1924.1924
Publikováno v:
Cancer. 91(7)
The importance of the bone marrow microenvironment in multiple myeloma is receiving increasing attention. Recent studies have suggested the importance of cytokine production and cell-cell contact by bone marrow stromal cells in the survival of myelom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b44b2291f4faaf65f9c520e50d10c03
https://pubmed.ncbi.nlm.nih.gov/11283920
https://pubmed.ncbi.nlm.nih.gov/11283920
Autor:
M S, Tallman, D, Neuberg, J M, Bennett, C J, Francois, E, Paietta, P H, Wiernik, G, Dewald, P A, Cassileth, M M, Oken, J M, Rowe
Publikováno v:
Blood. 96(7)
Acute megakaryocytic leukemia (AMegL) is a rare subtype of acute myeloid leukemia (AML) evolving from primitive megakaryoblasts. Because of its rarity and the lack of precise diagnostic criteria in the past, few series of adults treated with contempo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::479dc90b1de6cc26d6d22f23669bc321
https://pubmed.ncbi.nlm.nih.gov/11263442
https://pubmed.ncbi.nlm.nih.gov/11263442
Publikováno v:
British journal of haematology. 109(1)
Bone involvement is a central feature of multiple myeloma (MM). We investigated whether serum markers of osteoblastic and osteoclastic activity correlate with the presence of bone disease and survival in 313 MM patients enrolled in a phase III trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2144549e9e7ffcda41ef17539d66c5b2
https://pubmed.ncbi.nlm.nih.gov/10848778
https://pubmed.ncbi.nlm.nih.gov/10848778
Publikováno v:
British journal of haematology. 100(3)
T-helper blood populations are frequently altered in multiple myeloma (MM). We measured the numbers of naive and activated cell subsets in the blood of a cohort of both previously untreated and treated MM patients. Two-colour flow cytometry to detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1eac3b7ca9cf97a3eb8acc54d7c2d32
https://pubmed.ncbi.nlm.nih.gov/9504626
https://pubmed.ncbi.nlm.nih.gov/9504626
Autor:
J N, Winter, J, Andersen, J C, Reed, S, Krajewski, D, Variakojis, K D, Bauer, R I, Fisher, L I, Gordon, M M, Oken, S, Jiang, D, Jeffries, P, Domer
Publikováno v:
Blood. 91(4)
An inverse relationship between BCL-2 expression and cell cycle transition has been suggested by recent studies in murine models. To investigate the clinical relevance of these laboratory studies, a group of 116 paraffin-embedded non-Hodgkin's lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::129dd4a0d5f2aefc25988393d0ad7d5b
https://pubmed.ncbi.nlm.nih.gov/9454770
https://pubmed.ncbi.nlm.nih.gov/9454770
Publikováno v:
Cancer. 79(8)
The Eastern Cooperative Oncology Group (ECOG) performed a Phase III comparison of melphalan and prednisone (MP) with vincristine, carmustine (BCNU), melphalan, cyclophosphamide, and prednisone (VBMCP) in an attempt to determine which of these regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77f9774db3fbc86b9ac1717afb929eef
https://pubmed.ncbi.nlm.nih.gov/9118039
https://pubmed.ncbi.nlm.nih.gov/9118039
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 20(2)
Interferon-gamma (IFN-gamma) has the most potent immunomodulatory activity of all the interferons. This phase II-B study was performed to define time- and dose-dependent immunomodulatory effects mediated by IFN-gamma in a subset of patients with mela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d31d2d8b53436940388ae11bbd471a1
https://pubmed.ncbi.nlm.nih.gov/9087387
https://pubmed.ncbi.nlm.nih.gov/9087387
Autor:
J N, Winter, J, Andersen, D, Variakojis, L I, Gordon, R I, Fisher, M M, Oken, R S, Neiman, S, Jiang, K D, Bauer
Publikováno v:
Blood. 88(10)
The International Index is a powerful predictor of outcome in the aggressive non-Hodgkin's lymphomas that is based solely on clinical features. Proliferative activity (% S-phase) measured by flow cytometry has been reported to have prognostic signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2df12f852a842ffb23db2c0ad951c723
https://pubmed.ncbi.nlm.nih.gov/8916958
https://pubmed.ncbi.nlm.nih.gov/8916958